The Translational Research and Technology Transfer Unit is responsible to provide all the support to facilitate and promote the transfer of R&D activities and pre-clinical studies to the development of clinical studies and to enhance the adoptions of best practices in the community. It is responsible for identifying perspectives and perform analysis of technology transfer, creating the conditions for contracting with industry and other stakeholders, namely intellectual property implications.
AIBILI is an Interface Centre in the Health Sector of the National Technology Network. This recognition identifies AIBILI as the technology transfer centre acting as the facilitating partner between scientific institutions, enterprises and industry in order to bring novel products to the market. More information: https://www.ani.pt/pt/valorizacao-do-conhecimento/interface/cti-centros-de-tecnologia-e-inova%C3%A7%C3%A3o/
AIBILI is member of the Health Cluster Portugal (HCP) whose main objective is the promotion and implementation of initiatives and activities leading to the consolidation of a national cluster for competitiveness, innovation and technology in the health area.
More information: www.healthportugal.com
AIBILI is part of the Ophthalmology sub-cluster within HCP with the aim to increase Portuguese participation in international partnerships, attract national and foreign investment in health and make Portugal an important partner in ophthalmology healthcare and research. This Ophthalmology sub-cluster brings together public and private hospitals, clinics and industry, aiming to implement outcomes of ICHOM – The International Consortium for Health Outcomes Measurement, as a measure of value in the provision of healthcare, as well as support the development of a clinical research network in Portugal.
Daniel Sanches Fernandes